BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22269147)

  • 1. Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure.
    Hochstenbach K; van Leeuwen DM; Gottschalk RW; Gmuender H; Stølevik SB; Nygaard UC; Løvik M; Granum B; Namork E; van Loveren H; van Delft JH
    Mutat Res; 2012 Aug; 746(2):124-34. PubMed ID: 22269147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
    Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment.
    Hendriks G; Atallah M; Raamsman M; Morolli B; van der Putten H; Jaadar H; Tijdens I; Esveldt-van Lange R; Mullenders L; van de Water B; Vrieling H
    Mutat Res; 2011 May; 709-710():49-59. PubMed ID: 21382384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
    Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
    Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
    Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
    Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling.
    van Delft JH; van Agen E; van Breda SG; Herwijnen MH; Staal YC; Kleinjans JC
    Mutat Res; 2005 Aug; 575(1-2):17-33. PubMed ID: 15924884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
    Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
    Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time.
    Mathijs K; Brauers KJ; Jennen DG; Boorsma A; van Herwijnen MH; Gottschalk RW; Kleinjans JC; van Delft JH
    Toxicol Sci; 2009 Dec; 112(2):374-84. PubMed ID: 19770486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.
    Doktorova TY; Yildirimman R; Vinken M; Vilardell M; Vanhaecke T; Gmuender H; Bort R; Brolen G; Holmgren G; Li R; Chesne C; van Delft J; Kleinjans J; Castell J; Bjorquist P; Herwig R; Rogiers V
    Carcinogenesis; 2013 Jun; 34(6):1393-402. PubMed ID: 23393228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
    Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
    Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.
    Schaap MM; Zwart EP; Wackers PF; Huijskens I; van de Water B; Breit TM; van Steeg H; Jonker MJ; Luijten M
    Arch Toxicol; 2012 Nov; 86(11):1717-27. PubMed ID: 22710402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells.
    Harris AJ; Dial SL; Casciano DA
    Mutat Res; 2004 May; 549(1-2):79-99. PubMed ID: 15120964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents.
    van Leeuwen DM; Gottschalk RW; van Herwijnen MH; Moonen EJ; Kleinjans JC; van Delft JH
    Toxicol Sci; 2005 Jul; 86(1):200-10. PubMed ID: 15829617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
    Nioi P; Pardo ID; Sherratt PJ; Snyder RD
    Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
    Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
    Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
    Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
    Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.
    Park HJ; Oh JH; Park SM; Cho JW; Yum YN; Park SN; Yoon DY; Yoon S
    Arch Toxicol; 2011 Dec; 85(12):1627-40. PubMed ID: 21607683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
    Brambilla G; Martelli A
    Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.